EUVIMEDEUVIMED entdecken
Crossref

Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study

J Bremer iD, H H Pas, G F H Diercks, H J Meijer, S M van der Molen, A M Nijenhuis, L L van Nijen-Vos, P Morandé, M J Yubero, F Palisson, I Fuentes iD, A M G Pasmooij

Experimental Dermatology · 2024

DOI: 10.1111/exd.15035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von J Bremer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Epidermolysis Bullosa, Junctional, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, ANID, Chile, Fondo Nacional de Desarrollo Científico y Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermolysis bullosa (EB) is a heritable skin blistering disease caused by variants in genes coding for proteins that secure cell–cell adhesion and attachment of the epidermis to the dermis. Interestingly, several proteins involved in inherited EB are also associated with autoimmune blistering diseases (AIBD). In this study, we present a long‐term follow‐up of 15 patients suffering from recessive dystrophic or junctional EB. From these patients, 62 sera were analysed for the presence of autoantibodies associated with AIBD. We show that patients suffering from recessive dystrophic EB (RDEB) are more susceptible to developing autoantibodies against skin proteins than patients suffering from junctional EB (70% vs. 20%, respectively). Interestingly, no correlation with age was observed. Most patients showed reactivity to Type XVII collagen/linear IgA bullous dermatosis autoantigen ( n = 5; 33%), followed by BP230 ( n = 4; 27%), Type VII collagen ( n = 4; 27%) and laminin‐332 ( n = 1; 7%). The pathogenicity of these autoantibodies remains a subject for future experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa DystrophicaEpidermolysis BullosaEpidermolysis Bullosa, JunctionalAutoimmune DiseasesHumansAutoantibodiesSkin

Stichwörter der Autor:innen

Type VII collagenautoantibodiesdystrophic epidermolysis bullosajunctional epidermolysis bullosaserological follow-up

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Dermatology, Center for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • DEBRA Chile, Santiago, Chile.
  • Pediatrics and Pediatric Infectious Diseases of Clínica Alemana, Facultad de Medicina Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Servicio de Dermatología, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

ORCID-Profile: J Bremer, I Fuentes

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico, ANID, Chile
  • Fondo Nacional de Desarrollo Científico y Tecnológico

Zitieren

APA

Bremer, J., Pas, H. H., Diercks, G. F. H., Meijer, H. J., van der Molen, S. M., Nijenhuis, A. M., van Nijen-Vos, L. L., Morandé, P., Yubero, M. J., Palisson, F., Fuentes, I., & Pasmooij, A. M. G. (2024). Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study. Experimental Dermatology. https://doi.org/10.1111/exd.15035

Vancouver

Bremer J, Pas HH, Diercks GFH, Meijer HJ, van der Molen SM, Nijenhuis AM, et al. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study. Experimental Dermatology. 2024. doi:10.1111/exd.15035

BibTeX
@article{Bremer2024,
  author = {Bremer, J and Pas, H H and Diercks, G F H and Meijer, H J and van der Molen, S M and Nijenhuis, A M and van Nijen-Vos, L L and Morandé, P and Yubero, M J and Palisson, F and Fuentes, I and Pasmooij, A M G},
  title = {Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study},
  journal = {Experimental Dermatology},
  year = {2024},
  doi = {10.1111/exd.15035}
}
Kostenlos starten →